State Marijuana Legalization Aids Research Very Little
State Marijuana Legalization Aids Research Very Little
Recent federal announcements serve as reminders that in the US policy continues to outpace science when it comes to cannabis.
State Marijuana Legalization Aids Research Very Little
State Marijuana Legalization Aids Research Very Little

Recent federal announcements serve as reminders that in the US policy continues to outpace science when it comes to cannabis.

Recent federal announcements serve as reminders that in the US policy continues to outpace science when it comes to cannabis.

Cannabidiol
Ancient Wooden Pots from China Contain Cannabis Residue
Ancient Wooden Pots from China Contain Cannabis Residue
Chia-Yi Hou | Jun 12, 2019
A brazier and charred stones, thought to be part of burial ceremonies, preserve signs that people used the drug thousands of years ago.
Rediscovering Cannabis: The Pan-Cannabis Genome Project
Rediscovering Cannabis: The Pan-Cannabis Genome Project
Medicinal Genomics | May 8, 2019
Whether due to a changing regulatory climate, positive results from early clinical trials, or simply a desire to untangle cannabis’s mythology, scientists have rediscovered cannabis after ignoring it for decades. Find out how a plant's genetic signature translates into a compound profile!
Drug Approval Could Boost Research on Marijuana Treatment for Autism
Drug Approval Could Boost Research on Marijuana Treatment for Autism
Jessica Wright | Aug 17, 2018
Epidiolex, a cannabis-derived medicine for epilepsy, will prompt federal regulatory changes that could crack open access to study the plant.
FDA Approves First Marijuana-Derived Drug
FDA Approves First Marijuana-Derived Drug
Shawna Williams | Jun 25, 2018
As the CBD-based medication enters the market, the agency promises a crackdown on producers of cannabidiol products that make unproven claims.
Cannabidiol Eases Epileptic Seizures: Study
Cannabidiol Eases Epileptic Seizures: Study
Aggie Mika | May 26, 2017
Around 40 percent of children with an uncommon disorder had 50 percent fewer seizures while taking the marijuana derivative.